Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binqing Fu

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Pediatric Research|April 28, 2026
Proinflammatory monocyte-derived granulocyte-macrophage colony-stimulating factor fuels airway inflammation in bronchopulmonary dysplasiaShuShu Wang, Xuesong Wang, Dongyao Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2020
PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoterXiuxiu Xu, Yonggang Zhou, Binqing Fu, et al.
Frontiers in Immunology|October 28, 2017
KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis BWenting Li, Xiaokun Shen, Binqing Fu, et al.
Frontiers in Immunology|February 21, 2022
Human-Induced CD49a<sup>+</sup> NK Cells Promote Fetal GrowthXianghui Du, Huaiping Zhu, Defeng Jiao, et al.
Frontiers in Immunology|January 11, 2021
Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24<sup>+</sup>CD38<sup>hi</sup> B CellsBinqing Fu, Dongyao Wang, Xiaokun Shen, et al.
Translational Oncology|January 18, 2024
Tumor-infiltrating platelets promote the growth of lung adenocarcinomaXiaohui Li, Ming Li, Ziming Hu, et al.
Cancer Research|October 5, 2016
EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune SurveillanceXiaohu Zheng, Xiaolei Fan, Binqing Fu, et al.
Signal Transduction and Targeted Therapy|November 5, 2021
Restoration of HBV-specific CD8<sup>+</sup> T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapyDongyao Wang, Binqing Fu, Xiaokun Shen, et al.
Nature Immunology|October 23, 2019
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillanceXiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Scientific Reports|May 14, 2016
CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patientsChuang Guo, Xiaokun Shen, Binqing Fu, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Pediatric Research|April 28, 2026
Proinflammatory monocyte-derived granulocyte-macrophage colony-stimulating factor fuels airway inflammation in bronchopulmonary dysplasiaShuShu Wang, Xuesong Wang, Dongyao Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2020
PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoterXiuxiu Xu, Yonggang Zhou, Binqing Fu, et al.
Frontiers in Immunology|October 28, 2017
KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis BWenting Li, Xiaokun Shen, Binqing Fu, et al.
Frontiers in Immunology|February 21, 2022
Human-Induced CD49a<sup>+</sup> NK Cells Promote Fetal GrowthXianghui Du, Huaiping Zhu, Defeng Jiao, et al.
Frontiers in Immunology|January 11, 2021
Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24<sup>+</sup>CD38<sup>hi</sup> B CellsBinqing Fu, Dongyao Wang, Xiaokun Shen, et al.
Translational Oncology|January 18, 2024
Tumor-infiltrating platelets promote the growth of lung adenocarcinomaXiaohui Li, Ming Li, Ziming Hu, et al.
Cancer Research|October 5, 2016
EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune SurveillanceXiaohu Zheng, Xiaolei Fan, Binqing Fu, et al.
Signal Transduction and Targeted Therapy|November 5, 2021
Restoration of HBV-specific CD8<sup>+</sup> T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapyDongyao Wang, Binqing Fu, Xiaokun Shen, et al.
Nature Immunology|October 23, 2019
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillanceXiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Scientific Reports|May 14, 2016
CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patientsChuang Guo, Xiaokun Shen, Binqing Fu, et al.
Pageof 8